One of the scientists working on the European Prevention of Alzheimer\u2019s Dementia (EPAD) project, Professor Kaj Blennow, has been awarded the S\u00f6derberg Prize for his work on Alzheimer\u2019s disease. Prof. Blennow, of the University of Gothenburg, was awarded the prize of one million SEK (EUR 110,000) for his \u201cuniquely innovative research\u201d on 7 April during a ceremony at the Swedish Society of Medicine seminar.<\/p>\n
\u201cI am extremely happy! It is a great honour to receive the S\u00f6derberg Prize in Medicine,\u201d said Prof. Blennow (pictured), who will be performing cerebrospinal fluid (CSF) analyses for the EPAD Longitudinal Cohort Study (LCS).<\/p>\n
\u201cIt is also very gratifying that this type of clinically tied biochemical research receives attention. Currently there are a number of highly promising drugs that are in the final phase of their clinical trials, and on the day they hopefully become available for patients, there will be an enormous need to be able to diagnose Alzheimer\u2019s early in the course of the disease.\u201d<\/p>\n
The S\u00f6derberg Prize in Medicine rewards clinical medicine researchers whose results have been recognised for the past ten years. The prize, which has been awarded since 1986 by the Torsten S\u00f6derberg Foundation, is given to Laureates chosen in cooperation with the Swedish Society of Medicine.<\/p>\n
Professor Miia Kivipelto, EPAD WP4-lead, also gave a lecture during the seminar, called \u201cIs Alzheimer\u2019s Preventable?\u201d<\/p>\n